CC
EMMA

Cannell & Co’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Cannell & Co’s Portfolio EMMA Stock Details EMMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,333
Closed -$26K – 251
2019
Q2 		$26K Hold
3,333
– – ﹤0.01% 237
2019
Q1 		$28K Hold
3,333
– – ﹤0.01% 245
2018
Q4 		$15K Hold
3,333
– – ﹤0.01% 245
2018
Q3 		$32K Hold
3,333
– – ﹤0.01% 249
2018
Q2 		$36K Hold
3,333
– – ﹤0.01% 253
2018
Q1 		$24K Hold
3,333
– – ﹤0.01% 246
2017
Q4 		$68K Hold
3,333
– – ﹤0.01% 246
2017
Q3 		$76K Buy
+3,333
New +$77.5K ﹤0.01% 237

Other funds holding EMMA

MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Cannell & Co's EMMA Position: Q3 2019 in Review

Cannell & Co sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2019, closing a stake of 3,333 shares — an estimated $26K sold.

Cannell & Co first reported a position in EMMA in Q3 2017 and held it in 8 quarters. The position peaked at $76K in Q3 2017. 1 fund tracked by Wall St. Rank holds EMMA as of Q3 2019.

  • Cannell & Co reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Cannell & Co sold 3,333 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2019, an estimated $26K.
  • Cannell & Co first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2017 and held it in 8 quarters.
  • Cannell & Co's Emmaus Life Sciences, Inc. Common Stock position peaked at $76K in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2019.

Based on Cannell & Co's 13F filing for Q3 2019, filed 12 Nov 2019.